Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
16.5%
% of WDNA's 90 holdings also in PBE
50.0%
% of PBE's 28 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 4.0% | 5.4% | 4.0% |
|
BLUEPRINT MEDICINES CORP. | 2.5% | 2.6% | 2.5% |
|
VERACYTE INC | 2.5% | 2.8% | 2.5% |
|
UNITED THERAPEUTICS CORP | 1.8% | 5.0% | 1.8% |
|
SAREPTA THERAPEUTICS INC | 1.6% | 3.0% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to PBE
|
TWIST BIOSCIENCE CORP. | 3.8% |
 |
NOVOZYMES A/S-B SHARES | 3.5% |
|
VERICEL CORPORATION | 2.8% |
|
ELI LILLY & CO | 2.3% |
|
GERON CORP | 2.1% |
|
BRIDGEBIO PHARMA, INC. | 2.0% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.6% |
|
ALNYLAM PHARMACEUTICALS INC | 1.5% |
|
NEOGENOMICS INC | 1.5% |
WDNA Underweight Relative to PBE
|
INCYTE CORP | -4.8% |
|
BIOGEN IDEC INC | -4.1% |
|
ILLUMINA INC | -3.7% |
|
REGENERON PHARMACEUTICALS | -3.6% |
|
GILEAD SCIENCES INC | -3.5% |
|
AMGEN INC | -3.2% |
|
UNITED THERAPEUTICS CORP | -3.1% |
|
ROYALTY PHARMA PLC CLASS A | -3.1% |
|
NEUROCRINE BIOSCIENCES INC | -3.0% |
|
HALOZYME THERAPEUTICS INC | -3.0% |